Stanozolol recalls
The FDA has published 2 recalls involving Stanozolol since 2013. The latest was reported on 18 Nov 2015. Most were for sterility. Pacific Healthcare has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2013
Last 12 months0reported
Class I00% of total
Ongoing1latest 18 Nov 2015
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why stanozolol is recalled
Companies
By year
Ongoing stanozolol recalls
1 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Stanozolol (50 mg/ml and 100 mg/ml) Injection recalled | Lowlite Investments | Sterility | Nationwide |
All stanozolol recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Stanozolol 200 mg/ml Injection vial, Rx recalled by Pacific Healthcare | Pacific Healthcare | Sterility | CA, NJ |
| Drug | CLASS II | Stanozolol (50 mg/ml and 100 mg/ml) Injection recalled | Lowlite Investments | Sterility | Nationwide |
Should you stop taking Stanozolol?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.